Marijuana Stocks In 2027: New Risks And Opportunities For Investors
MarijuanaStocks11/9/2026Neutral
TRLV
Trulieve Cannabis Corp.NYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.97B
P/E Ratio
—
EPS
$-2.43
Beta
1.92
52W High
$13.28
52W Low
$7.17
50-Day MA
$11.21
200-Day MA
$8.89
Dividend Yield
—
Profit Margin
-41.20%
Forward P/E
20.83
PEG Ratio
—
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp. (TRLV) is a prominent player in the US cannabis market, distinguished by its comprehensive vertical integration that encompasses cultivation, production, and retail distribution of cannabis products. With a significant presence in critical states like Florida, Trulieve is dedicated to delivering high-quality and innovative solutions that cater to a diverse consumer base. The company’s robust commitment to community involvement and sustainable business practices not only enhances its brand reputation but also positions Trulieve strategically for long-term growth amidst the dynamic landscape of the cannabis industry.
Fundamentals
| Revenue (TTM) | $1.08B |
| Gross Profit (TTM) | $655.55M |
| EBITDA | $288.66M |
| Operating Margin | 18.40% |
| Return on Equity | -45.60% |
| Return on Assets | 3.27% |
| Revenue/Share (TTM) | $5.62 |
| Book Value | $4.01 |
| Price-to-Book | 2.57 |
| Price-to-Sales (TTM) | 1.82 |
| EV/Revenue | 2.178 |
| EV/EBITDA | 6.07 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -20.10% |
| Shares Outstanding | $170.41M |
| Float | $148.77M |
| % Insiders | 1.23% |
| % Institutions | 25.45% |
Historical Volatility
HV 10-Day
67.47%
HV 20-Day
58.96%
HV 30-Day
63.31%
HV 60-Day
58.53%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($18.18 target)
1
Strong Buy6
BuyLatest News
Trulieve Cannabis Corp. (TRLV) Q3 2026 Earnings Call Transcript
Trulieve Cannabis Corp. (TRLV) Q3 2026 Earnings Call Transcript
Seeking Alpha11/5/2026Neutral
Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations
TALLAHASSEE, Fla., Nov. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for medical marijuana dispensaries as part of the initial registrations issued by the U.S. Drug Enforcement Administration (DEA).
PRNewsWire11/2/2026Neutral
Marijuana Stocks And The Changing U.S. Cannabis Industry
MarijuanaStocks10/28/2026Neutral
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
Zacks Investment Research10/9/2026Positive
Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet
TALLAHASSEE, Fla., Oct. 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the full repayment of an approximately $65 million mortgage notes payable secured by a cultivation site in Jefferson County, Florida, thereby reducing outstanding debt to approximately $225 million.
PRNewsWire10/7/2026Neutral
Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026
TALLAHASSEE, Fla., Oct. 6, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV ) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., will hold a conference call on Thursday, November 5, 2026 at 8:30 AM Eastern Time following the release of its third quarter 2026 financial results.
PRNewsWire10/6/2026Neutral
MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick
I reiterate my Buy rating on AdvisorShares Pure US Cannabis ETF despite the DEA pausing rescheduling hearings. MSOS remains attractive as the rescheduling catalyst is delayed, not canceled, and underlying holdings appear reasonably valued. Trulieve Cannabis Corp., MSOS's largest holding, stands out due to its Florida medical sales focus and normalized tax rates.
Seeking Alpha10/1/2026Positive
3 Cannabis Stocks to Watch Heading Out of September
The marijuana industry is entering another important period for investors as September 2026 gets underway. Cannabis stocks have experienced significant volatility over the past several years. However, several major operators continue building their businesses despite challenging industry conditions.
MarijuanaStocks9/29/2026Neutral
Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas
Perpetual Royalty-Free License Covers Alien Labs and Connected Brands TALLAHASSEE, Fla., Sept. 28, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S, today announced a licensing deal with Connected for the exclusive rights to genetics, trademarks, and proprietary know-how to produce and sell Alien Labs and Connected branded cannabis products in Florida and Texas.
PRNewsWire9/28/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TRLV and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 11/9/2026